نتایج جستجو برای: methotrexate resistance

تعداد نتایج: 394288  

Journal: :The Biochemical journal 2003
Hideyuki Mitomo Ryo Kato Akiko Ito Shiho Kasamatsu Yoji Ikegami Isao Kii Akira Kudo Eiry Kobatake Yasuhiro Sumino Toshihisa Ishikawa

Overexpression of the ATP-binding cassette transporter ABCG2 reportedly causes multidrug resistance, whereas altered drug-resistance profiles and substrate specificity are implicated for certain variant forms of ABCG2. At least three variant forms of ABCG2 have been hitherto documented on the basis of their amino acid moieties (i.e., arginine, glycine and threonine) at position 482. In the pres...

Journal: :The Journal of biological chemistry 1982
A Rosowsky J E Wright H Shapiro P Beardsley H Lazarus

A new fluorescent methotrexate analogue (PT430) was synthesized as a reported ligand for dihydrofolate reductase. The analogue was prepared by attachment of lysine in place of the glutamate side chain of methotrexate and conjugation to fluorescein isothiocyanate via the epsilon-amino group of lysine. Spectrophotometric enzyme inhibition assays showed PT430 to be about one-tenth as potent as met...

Journal: :Cancer research 1990
C J Allegra D Boarman

Previous investigations have suggested that high-dose methotrexate with leucovorin rescue is a potentially useful strategy for overcoming antifolate resistance. Interactions between methotrexate (MTX) and leucovorin and their respective metabolites appear to occur at multiple intracellular sites, including dihydrofolate reductase (MTX/MTX polyglutamates versus dihydrofolate) and other folate-de...

Journal: :International journal of cancer 2006
Josep M de Anta Clara Mayo Francesc Solé Marta Salido Blanca Espinet Cristina Corzo Myriam Petzold Olaya Villa Sergi Serrano Francisco X Real Xavier Mayol

Genetic instability leads to tumor heterogeneity, which in turn provides a source of cell variants responsible for drug resistance. However, the source of resistant cells during the process of acquired resistance is poorly understood. Our aim has been to characterize the mechanism by which acquired resistance to methotrexate emerges during the course of cancer cell treatment in vitro. We recent...

Journal: :Journal of Investigative Dermatology 1980

Journal: :Cancer research 1984
H Rath T Tlsty R T Schimke

We have examined the time required for mouse 3T6 cells to become resistant to 200 nM methotrexate by three selection protocols: (a) a single-step 0 to 200 nM dose; (b) a two-step 0 to 80 to 200 nM dose; and (c) a multistep 0 to 40 to 80 to 120 to 160 to 200 nM dose. An initial inoculum of 5 X 10(5) cells was grown to 10(6) cells at each increment of methotrexate, reduced to 5 X 10(5) cells, and...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 1987
D Dudits E Maroy T Praznovszky Z Olah J Gyorgyey R Cella

Transfer of methotrexate and 5-methyltryptophan resistance from carrot (Daucus carota) to tobacco (Nicotiana tabacum) was achieved by fusion between leaf mesophyll protoplasts of tobacco and irradiated cell culture protoplasts of carrot. Some of the regenerated somatic hybrids exhibited normal tobacco morphology with coexpression and independent segregation of the transferred resistance markers...

Journal: :The Journal of pharmacology and experimental therapeutics 2005
Lalitha R Belur Rohaizah I James Chad May Miechaleen D Diers Debra Swanson Roland Gunther R Scott McIvor

Methotrexate (MTX) is an effective antitumor agent that has been demonstrated to be particularly useful in the treatment of hematopoietic neoplasms but causes substantial hematologic and gastrointestinal toxicity. We previously demonstrated that transplantation with transgenic marrow expressing drug-resistant dihydrofolate reductase (DHFR) into animals preconditioned by irradiation substantiall...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید